11/28
07:05 pm
actu
How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06% [Yahoo! Finance]
Medium
Report
How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06% [Yahoo! Finance]
11/26
02:00 pm
actu
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
08:07 am
actu
Actuate Therapeutics (NASDAQ:ACTU) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Medium
Report
Actuate Therapeutics (NASDAQ:ACTU) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/15
07:05 pm
actu
Here's Why We're Watching Actuate Therapeutics' (NASDAQ:ACTU) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Watching Actuate Therapeutics' (NASDAQ:ACTU) Cash Burn Situation [Yahoo! Finance]
11/14
01:10 pm
actu
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
02:37 pm
actu
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/23
08:07 am
actu
Actuate Therapeutics (NASDAQ:ACTU) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Medium
Report
Actuate Therapeutics (NASDAQ:ACTU) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
9/22
09:12 am
actu
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months [Yahoo! Finance]
Low
Report
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months [Yahoo! Finance]
9/22
08:45 am
actu
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
Medium
Report
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
9/20
01:09 am
actu
Actuate Therapeutics (NASDAQ:ACTU) was upgraded by analysts at
Wall Stre
Medium
Report
Actuate Therapeutics (NASDAQ:ACTU) was upgraded by analysts at
Wall Stre
9/11
04:01 pm
actu
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
Low
Report
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
9/10
08:31 am
actu
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
High
Report
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
9/9
04:46 pm
actu
Actuate Therapeutics Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
High
Report
Actuate Therapeutics Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
9/9
04:07 pm
actu
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
High
Report
Actuate Therapeutics Announces Proposed Public Offering of Common Stock